Discovery of NMS-0963, a potent, selective and orally available Syk inhibitor with outstanding preclinical activity in diffuse large B-cell lymphoma

L. Buffa, G. Cervi, R. D’Alessio, S. Bindi, A. Burocchi, G. Canevari, M. Modugno, I. Motto, G. Saturno, P. Orsini
58th International Conference on Medicinal Chemistry (RICT 2024); July 3-5, 2024; Bordeaux, France